Dallas, TX – October 30, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $50 Million valuation for its cannabis extract biopharmaceutical technology.  The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments.  KALY management has entered discussions with the investor but not formally expressed at this...

read more